Tag: Identified

  • Medicine Nobel To Trio Who Identified Immune System’s ‘Security Guards’

    Medicine Nobel To Trio Who Identified Immune System’s ‘Security Guards’

    A US-Japanese trio on Monday won the Nobel Prize in Medicine for research into how the immune system is kept in check by identifying its “security guards”, the Nobel jury said.

    The discoveries by Mary E. Brunkow and Fred Ramsdell of the United States and Japan’s Shimon Sakaguchi have been decisive for understanding how the immune system functions and why we do not all develop serious autoimmune diseases.

    Sakaguchi, a professor at the Immunology Frontier Research Centre in Osaka, told Swedish broadcaster Sveriges Radio: “It’s an honour for me. I’m looking forward to visiting Stockholm in December” to receive the award in person.

    The Nobel committee was however unable to reach the two US-based laureates to break the news to them in person.

    “If you hear this, call me,” the head of the Nobel Assembly, Thomas Perlmann, joked at the press conference announcing the winners.

    The three won the prize for research that identified the immune system’s “security guards”, called regulatory T-cells.

    Their work concerns “peripheral immune tolerance” that prevents the immune system from harming the body, and has led to a new field of research and the development of potential medical treatments now being evaluated in clinical trials.

    “The hope is to be able to treat or cure autoimmune diseases, provide more effective cancer treatments and prevent serious complications after stem cell transplants,” the jury said.

    Sakaguchi made the first key discovery in 1995.

    At the time, many researchers were convinced that immune tolerance only developed due to potentially harmful immune cells being eliminated in the thymus, through a process called “central tolerance”.

    Sakaguchi, 74, showed that the immune system is more complex and discovered a previously unknown class of immune cells, which protect the body from autoimmune diseases.

    Brunkow, born in 1961 and a senior project manager at the Institute for Systems Biology in Seattle, and Ramsdell, a 64-year-old senior advisor at Sonoma Biotherapeutics in San Francisco, made the other key discovery in 2001, when they were able to explain why certain mice were particularly vulnerable to autoimmune diseases.

    “They had discovered that mice have a mutation in a gene that they named Foxp3,” the jury said.

    “They also showed that mutations in the human equivalent of this gene cause a serious autoimmune disease, IPEX.”

    Two years later, Sakaguchi was able to link these discoveries.

    The trio will receive their prize — a diploma, a gold medal and $1.2 million split three ways — at a formal ceremony in Stockholm on December 10.

    Researchers from major US institutions typically dominate the Nobel science prizes, due largely to the US’ longstanding investment in basic science and academic freedoms.

    But that could change down the line following massive US budget cuts to science programmes announced by President Donald Trump.

    Since January, the US National Institutes of Health (NIH) has terminated 2,100 research grants totalling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch.

    Thomas Perlmann, secretary general of the committee that awards the Nobel Prize for Medicine, told AFP it was “no coincidence that the US has by far the most Nobel laureates”.

    “But there is now a creeping sense of uncertainty about the US’ willingness to maintain their leading position in research,” he said.

    Trump has meanwhile made no secret of the fact that he wants to win a Nobel himself — the Peace Prize.

    Nobel experts have however said his “America First” policies and divisive style give him little chance.

    “It’s completely unthinkable,” Oeivind Stenersen, a historian who has conducted research and co-written a book on the prize, told AFP.

    “(Trump) is in many ways the opposite of the ideals that the Nobel Prize represents,” he said, citing “multilateral cooperation” as an example.

    Trump “follows his own path, unilaterally,” Stenersen added.

    Sudan’s networks of volunteers Emergency Response Rooms (ERR) helping people survive war and famine — are seen as a possible contender this year, as are media watchdogs the Committee to Protect Journalists, Reporters Without Borders, and Yulia Navalnaya, the widow of Kremlin critic Alexei Navalny.

    Source link

  • New Chemical Identified In U.S. Tap Water, Scientists Urge Investigation Into Its Toxicity

    New Chemical Identified In U.S. Tap Water, Scientists Urge Investigation Into Its Toxicity

    Scientists have identified a new chemical byproduct in tap water consumed by millions of Americans, solving a decades-long mystery. This compound, formed during water purification with chloramine, raises health concerns for roughly 113 million people and warrants further investigation into its potential toxicity.

    Chloramine is a disinfectant created by combining chlorine with ammonia. It is preferred over chlorine in many water treatment systems due to its greater stability, which results in lower levels of disinfectant byproducts compared to chlorine.

    Although researchers first noted the unidentified chemical byproduct in tap water treated with chloramine nearly 40 years ago, its exact details were not known. In a recent study published in Science, scientists used advanced analytical methods to uncover its structure, which is now officially named chloronitramide anion.

    The researchers detected chloronitramide anion in all 40 samples taken from 10 drinking water systems located in seven states. It was not seen in ultrapure water, or drinking water treated without chlorine-based disinfectants.

    “It’s well recognized that when we disinfect drinking water, there is some toxicity that’s created. Chronic toxicity, really. A certain number of people may get cancer from drinking water over several decades. But we haven’t identified what chemicals are driving that toxicity. A major goal of our work is to identify these chemicals and the reaction pathways through which they form,” Julian Fairey, first co-author on the paper said in a news release.

    The study represents a significant breakthrough, as it successfully identified chloronitramide anion and determined its structure.

    “It’s a very stable chemical with a low molecular weight. It’s a very difficult chemical to find. The hardest part was identifying it and proving it was the structure we were saying it was,” Fairey noted.

    Although the toxicity of chloronitramide anion remains uncertain, researchers have raised concerns due to its widespread presence and structural similarities to other toxic compounds. They stress the need for further investigation by academics and regulatory agencies, such as the U.S. Environmental Protection Agency.

    “Even if it is not toxic, finding it can help us understand the pathways for how other compounds are formed, including toxins. If we know how something is formed, we can potentially control it,” Fairey added.

    Source link